Genome-wide Investigation of in Vivo EGR-1 Binding Sites in Monocytic Differentiation
Overview
Authors
Affiliations
Background: Immediate early genes are considered to play important roles in dynamic gene regulatory networks following exposure to appropriate stimuli. One of the immediate early genes, early growth response gene 1 (EGR-1), has been implicated in differentiation of human monoblastoma cells along the monocytic commitment following treatment with phorbol ester. EGR-1 has been thought to work as a modifier of monopoiesis, but the precise function of EGR-1 in monocytic differentiation has not been fully elucidated.
Results: We performed the first genome-wide analysis of EGR-1 binding sites by chromatin immunoprecipitation with promoter array (ChIP-chip) and identified EGR-1 target sites in differentiating THP-1 cells. By combining the results with previously reported FANTOM4 data, we found that EGR-1 binding sites highly co-localized with CpG islands, acetylated histone H3 lysine 9 binding sites, and CAGE tag clusters. Gene Ontology (GO) analysis revealed enriched terms, including binding of molecules, in EGR-1 target genes. In addition, comparison with gene expression profiling data showed that EGR-1 binding influenced gene expression. Moreover, observation of in vivo occupancy changes of DNA binding proteins following PMA stimulation indicated that SP1 binding occupancies were dramatically changed near EGR-1 binding sites.
Conclusions: We conclude that EGR-1 mainly recognizes GC-rich consensus sequences in promoters of active genes. GO analysis and gene expression profiling data confirm that EGR-1 is involved in initiation of information transmission in cell events. The observations of in vivo occupancy changes of EGR-1 and SP1 suggest that several types of interplay between EGR-1 and other proteins result in multiple responses to EGR-1 downstream genes.
Endosomal Arl4A attenuates EGFR degradation by binding to the ESCRT-II component VPS36.
Lin S, Lin M, Liu T, Tsai Y, Tsai M, Lee F Nat Commun. 2023; 14(1):7859.
PMID: 38030597 PMC: 10687025. DOI: 10.1038/s41467-023-42979-9.
Isagulieva A, Kaluzhny D, Beniaminov A, Soshnikova N, Shtil A Int J Mol Sci. 2022; 23(16).
PMID: 36012127 PMC: 9408465. DOI: 10.3390/ijms23168871.
Salguero-Aranda C, Beltran-Povea A, Postigo-Corrales F, Hitos A, Diaz I, Caballano-Infantes E Int J Mol Sci. 2022; 23(7).
PMID: 35409280 PMC: 8999925. DOI: 10.3390/ijms23073920.
Gomes A, Ilter D, Low V, Rosenzweig A, Shen Z, Schild T Cancer Cell. 2019; 36(4):402-417.e13.
PMID: 31564638 PMC: 6801101. DOI: 10.1016/j.ccell.2019.08.006.
Yang W, Kang Y, Zhao Q, Bi L, Jiao L, Gu Y J Cell Mol Med. 2019; 23(9):6193-6202.
PMID: 31237749 PMC: 6714142. DOI: 10.1111/jcmm.14501.